IGHG1 ORF Vector

IGHG1 ORF Vector

Catalog Number:
OL01293792APP
Mfr. No.:
2438001
Price:
$298
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • The IGHG1 ORF Vector holds the gene (cloned by a restriction enzyme-independent method) between an AflII and EcoRV cut site. Inserts are flanked by and can be excised using AflII and EcoRV as long as inserts do not contain any internal AflII and EcoRV sites. In the case that the insert contains these internal cut sites, the end user can PCR amplify the insert with preferred restriction sites for subcloning.

          Please contact us at for specific academic pricing.

      • Properties
        • Categories
          pORF Vector
          Appearance
          Clear Liquid
          Other Properties
          Vector Size: 2596bp
          Insert Size: BC019337: 1395; BC014258: 1413; BC006402: 1440
          Accession Number: BC019337; BC014258; BC006402
          This gene is available from: Human
          Gene Name: IGHG1
          HGNC ID: HGNC:5525

          * All vectors and viral particles are for research use ONLY and NOT for therapeutic/diagnostic applications.

      • Reference
        • Wang, Q., Yu, H., Yu, H., Ma, M., Ma, Y., & Li, R. "miR‑223‑3p/TIAL1 interaction is involved in the mechanisms associated with the neuroprotective effects of dexmedetomidine on hippocampal neuronal cells in vitro" Molecular Medicine Reports. : (2018). DOI: 10.3892/mmr.2018.9742.
          Xu, T., He, B. S., Pan, B., Pan, Y. Q., Sun, H. L., Liu, X. X., ... & Wang, S. K. "MiR‐142‐3p functions as a tumor suppressor by targeting RAC1/PAK1 pathway in breast cancer" Journal of Cellular Physiology. : (2019).
          Zhang, B., Roosmalen, I. A. M., Reis, C. R., Setroikromo, R., & Quax, W. J. "Death receptor 5 is activated by fucosylation in colon cancer cells" The FEBS Journal 286(3):555–571 (2019). DOI: 10.1111/febs.14742.
          Zhao, Q., Zhao, S., Li, J., Zhang, H., Qian, C., Wang, H., … Zhao, Y. "TCF7L2 activated HOXA-AS2 decreased the glucocorticoid sensitivity in acute lymphoblastic leukemia through regulating HOXA3/EGFR/Ras/Raf/MEK/ERK pathway" Biomedicine & Pharmacotherapy 109:1640–1649 (2019). DOI: 10.1016/j.biopha.2018.10.046.

    Note: If you don't receive our verification email, do the following:

  • Copyright © Amerigo Scientific. All rights reserved.